Recurrent Adult Soft Tissue Sarcoma Recruiting Phase 2 Trials for Topotecan (DB01030)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02357810Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone SarcomasTreatment